Low-Dose Dexamethasone Following IVIG in Pediatric Inflammatory Multisystem Syndrome in Temporal Association with COVID-19 (PIMS-TC)

Indian J Pediatr. 2021 Mar;88(3):301-302. doi: 10.1007/s12098-020-03509-3. Epub 2020 Oct 6.

Authors

Priyanka Meena¹, Pallavi², Devendra Mishra¹, Urmila Jhamb¹, Meenakshi Aggarwal³

Affiliations

¹ Department of Pediatrics, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, 110002, India.
² Department of Pediatrics, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, 110002, India. pallavi86.delhi@gmail.com.
³ Department of Microbiology, Kalawati Saran Children's Hospital & Lady Hardinge Medical Hospital, New Delhi, India.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

COVID-19 Drug Treatment*
Child
Dexamethasone / administration & dosage
Dexamethasone / therapeutic use*
Humans
Immunoglobulins, Intravenous / therapeutic use*
Male
Systemic Inflammatory Response Syndrome / drug therapy*

Substances

Immunoglobulins, Intravenous
Dexamethasone

Supplementary concepts

pediatric multisystem inflammatory disease, COVID-19 related